A carregar...
Identification and Characterization of Two Novel Oncogenic mTOR Mutations
Mammalian target of rapamycin (mTOR) signaling is often aberrantly activated, particularly when genetically activated, in human cancers. mTOR inhibitors targeting the activated mTOR signaling are highly promising anti-cancer drugs. Knowing the activating genetic change in mTOR can help guide the use...
Na minha lista:
| Publicado no: | Oncogene |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597304/ https://ncbi.nlm.nih.gov/pubmed/30918329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-019-0787-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|